Lower the barrier to entry for LNP formulation and drug development, using pre-optimized lipid compositions to fast-track screening and proof-of-concept studies. Discover how to confidently produce LNPs using prepared reagents and protocols, designed to validate RNA drug delivery quickly and easily without being a formulation expert.
The impact of RNA-LNP experience extends beyond formulation, amplifying benefits across development stages to de-risk and accelerate process development. In this scientific poster, review LNP data demonstrating in vitro protein expression and in vivo immunogenicity across payloads for RNA vaccine applications, using a scalable formulation that maintains potency up to GMP scale.
Process development is a challenge for any drug developer, scaling up batch volumes while maintaining the quality and performance of the RNA-LNPs. Learn how leveraging LNP experience accelerates downstream filtering process development and can significantly reduce batch processing time and maximize yield.
Scaling up RNA-LNPs from discovery to GMP manufacturing is a complex process, simplified by outsourcing specialized expertise and resources. Gain insights into some of the common challenges of RNA-LNP drug manufacturing, along with the advantages of collaborating with a knowledgeable team that can be a catalyst for successful drug development.
Join us on October 3 at 10 am EST to explore the complexity and diversity of mRNA-LNP therapeutics, and their challenges for development and manufacturing. In this webinar, we explore strategies to de-risk and accelerate the development of promising candidates for clinical evaluation, featuring a successful collaboration with Replicate Bioscience, developing a self-replicating RNA (srRNA) vaccine for infectious disease.
This website uses cookies to ensure you get the best experience on our website. Learn more
